<code id='1D859012F7'></code><style id='1D859012F7'></style>

<acronym id='1D859012F7'></acronym>

<center id='1D859012F7'><center id='1D859012F7'><tfoot id='1D859012F7'></tfoot></center><abbr id='1D859012F7'><dir id='1D859012F7'><tfoot id='1D859012F7'></tfoot><noframes id='1D859012F7'>

<optgroup id='1D859012F7'><strike id='1D859012F7'><sup id='1D859012F7'></sup></strike><code id='1D859012F7'></code></optgroup>

<b id='1D859012F7'><label id='1D859012F7'><select id='1D859012F7'><dt id='1D859012F7'><span id='1D859012F7'></span></dt></select></label></b><u id='1D859012F7'></u>

~~<i id='1D859012F7'><strike id='1D859012F7'><tt id='1D859012F7'><pre id='1D859012F7'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

knowledge

author：focus 2025-09-28 07:55:12 Page View：2

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

advertisement

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Lilly’s weekly insulin works as well as daily products, new studies show
Next article： Duchenne breakthrough therapy leaves behind pioneering families

focus

Duchenne breakthrough therapy leaves behind pioneering families

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

EU climate chief is concerned over the expansion of the coal industry in China

EU climate chief is concerned over the expansion of the coal industry in China

FILE-Smokebillowsfromchimneysofthecoolingtowersofacoal-firedpowerplantinDadong,Shanxiprovince,China,

Psychedelics group wrestles with new pharma identity

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

ORLANDO,Fla.--AMichiganmanaccusedofattackingapoliceofficerwithaflagpoleduringtheinsurrectionattheU.S

read more